Clinical trial
Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer
NCT00097851 is registered in ClinicalTrials.gov with Cellxpert Biotechnology Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Docetaxel With PI-88 in Patients With Advanced Non-Small-Cell Lung Cancer
- Lead sponsor
- Cellxpert Biotechnology Corp.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2004
- Completion date
- July 31, 2006
- Enrollment
- 100
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.